Great editorial Annals of Int Med Gil Welch inspired me to talk about real questions around cancer screening. John Mandrola, MD Eric Topol Study Puts a $43 Billion Yearly Price Tag on Cancer Screening nytimes.com/2024/08/05/hea…

GRAIL in the NHS. politically driven and unlikely to benefit patients. bmj.com/content/386/bm… thanks to Richard Sullivan Clare Turnbull- Prof/NHS Dr Paul Pharoah (R soul) 🇪🇺🇵🇬🇿🇦🇬🇧 and the many anon people who spoke to us. David Cameron Nadhim Zahawi

Slightly obvious (?) hot tip: 🔥 If someone was completely wrong about everything to do with mpox before, do not get your information about mpox (or anything else?) from them now Simples

"However well-intentioned, screening is a symbolic health equity solution that serves more the interests of those with advanced degrees, than those with high school educations." 🔥 piece from Ade Adamson, MD MPP & co statnews.com/2024/08/21/can…

shibley Mary 🇮🇪 🇵🇸 Robert Howard Simon Bottery Neil Crowther Richard Humphries 💚 NHS England Prof Dan Morgan has recently written a great article on 'medical minimalism'. Not that the secondary care clinicians globally are listening to a word he has written and they are being wildly egged on by all these single issue patient charities archive.ph/nc2BH

Diagnostic stewardship is a core element of diagnostic excellence and radiologists need to be involved in co-leading these programs/interventions. Speaking with Dan Morgan on AJR Podcast doi.org/10.2214/AJR.24…

In this episode of the AJR Podcast Series on Diagnostic Excellence and Error, Francis Deng, MD and Dan Morgan discuss diagnostic stewardship. ajronline.org/doi/10.2214/AJ…

To sum up: the frequent omission of EPIC-SR highlights the significant bias in reporting of clinical trial results, particularly those with negative outcomes. This selective reporting continues to skew the perceived effectiveness of treatments like Paxlovid. End 🧵10/10